<p>Background: Primary progressive aphasia (PPA) is a clinical syndrome characterized by the neurodegeneration of language brain systems. Three main clinical forms (non-fluent, semantic, and logopenic PPA) have been recognized, but applicability of the classification and the capacity to predict the underlying pathology is controversial. We aimed to study FDG-PET imaging data in a large consecutive case series of patients with PPA to cluster them into different subtypes according to regional brain metabolism.</p><p>Methods: 122 FDG-PET imaging studies belonging to 91 PPA patients and 28 healthy controls were included. We developed a hierarchical agglomerative cluster analysis with Ward's linkage method, an unsupervised clustering algorithm. ...
Objective A new classification of primary progressive aphasia (PPA) was recently proposed to differe...
Objectives: The logopenic variant of primary progressive aphasia is an atypical clinical variant of ...
A joint effort of the European Association of Nuclear Medicine (EANM) and the European Academy of Ne...
Background: Primary progressive aphasia (PPA) is a clinical syndrome characterized by the neurodegen...
Background and Objective: Primary progressive aphasia (PPA) is a clinical syndrome due to different ...
Importance:The ability to predict the pathology underlying different neurodegenerative syndromes is ...
Neuroimaging studies have described the brain alterations in primary progressive aphasia (PPA) varia...
Objective: Alzheimer’s disease (AD) is found at autopsy in up to one third of patients with primary ...
Recently, diagnostic clinical and imaging criteria for primary progressive aphasia (PPA) have been r...
Objectives: Alzheimer’s disease (AD) is the cause of approximately 30% of cases of language onset de...
<p>Background: F-18-fluordeoxyglucose positron emission tomography (FDG-PET) is widely used for disc...
We present a clinical-neuroimaging study in a series of patients with a clinical diagnosis of semant...
Background: Primary progressive aphasia (PPA) is a progressive language disorder associated with atr...
Clinical assessment of frontotemporal lobar degeneration (FTLD)/primary progressive aphasia (PPA) pa...
OBJECTIVE: To estimate the prevalence of amyloid-positivity, defined by PET/CSF biomarkers and/or ne...
Objective A new classification of primary progressive aphasia (PPA) was recently proposed to differe...
Objectives: The logopenic variant of primary progressive aphasia is an atypical clinical variant of ...
A joint effort of the European Association of Nuclear Medicine (EANM) and the European Academy of Ne...
Background: Primary progressive aphasia (PPA) is a clinical syndrome characterized by the neurodegen...
Background and Objective: Primary progressive aphasia (PPA) is a clinical syndrome due to different ...
Importance:The ability to predict the pathology underlying different neurodegenerative syndromes is ...
Neuroimaging studies have described the brain alterations in primary progressive aphasia (PPA) varia...
Objective: Alzheimer’s disease (AD) is found at autopsy in up to one third of patients with primary ...
Recently, diagnostic clinical and imaging criteria for primary progressive aphasia (PPA) have been r...
Objectives: Alzheimer’s disease (AD) is the cause of approximately 30% of cases of language onset de...
<p>Background: F-18-fluordeoxyglucose positron emission tomography (FDG-PET) is widely used for disc...
We present a clinical-neuroimaging study in a series of patients with a clinical diagnosis of semant...
Background: Primary progressive aphasia (PPA) is a progressive language disorder associated with atr...
Clinical assessment of frontotemporal lobar degeneration (FTLD)/primary progressive aphasia (PPA) pa...
OBJECTIVE: To estimate the prevalence of amyloid-positivity, defined by PET/CSF biomarkers and/or ne...
Objective A new classification of primary progressive aphasia (PPA) was recently proposed to differe...
Objectives: The logopenic variant of primary progressive aphasia is an atypical clinical variant of ...
A joint effort of the European Association of Nuclear Medicine (EANM) and the European Academy of Ne...